Clinical trial
ARCHIPELAGO: Irbesartan in Patients With Acute Coronary Syndrome Without ST…
NCT00296218 · Sanofi, Industry · Completed
Key facts
| NCT number | NCT00296218 |
|---|---|
| Title | ARCHIPELAGO: Irbesartan in Patients With Acute Coronary Syndrome Without ST Segment Elevation |
| Official title | Randomized Comparison of a Two-month Regimen of Irbesartan Versus Enalapril on Cardiovascular Markers in Patients With Acute Coronary Syndrome Without ST Segment Elevation. |
| Lead sponsor | Sanofi, Industry |
| Collaborators | Bristol-Myers Squibb Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Myocardial Ischemia, Hypertension |
| Intervention type | Drug |
| Interventions | Irbesartan |
| Enrollment | 440 |
| Start date | Feb 1, 2006 |
| Primary completion | Mar 1, 2007 |
| First posted | Feb 24, 2006 |
| Last update posted | Oct 15, 2009 |
| Countries | Belgium, Canada, France, Germany, Hungary, Italy, Netherlands, Spain, Switzerland, United Kingdom, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: